Interestingly, in the context of obesity, we show here that Mat1a deficiency, rather than worsening the liver status, decreased the de novo lipogenesis in the liver, without affecting FAO, preventing lipid accumulation without producing liver fibrosis or infiltration. The gene discussed is MAT1A; the disease is obesity disorder.